Table: Sumitomo Pharma -2023/24 parent results

Sumitomo Pharma

14/05/2024 05:00

May 14 (Reuters)- 
          Sumitomo Pharma Co., Ltd. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended        Year ended       Year to       NEXT   
                Mar 31, 2024      Mar 31, 2023   Mar 31, 2025     YEAR     
                   LATEST           YEAR-AGO        COMPANY      COMPANY   
                  RESULTS           RESULTS        FORECAST    H1 FORECAST 
  Sales            98.21             231.76                                
                (-57.6 pct)       (-23.4 pct)                              
  Operating      loss 50.00           54.94                                
                                  (-50.6 pct)                              
  Recurring      loss 6.53           104.77                                
                                  (-25.6 pct)                              
  Net           loss 588.12       loss 182.96                              
  EPS        loss 1,480.32 yen  loss 460.52 yen                            
  Ann Div           NIL            21.00 yen          NIL                  
  -Q2 Div           NIL            14.00 yen          NIL                  
  -Q4 Div           NIL             7.00 yen          NIL                  
  
  NOTE - Sumitomo Pharma Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4506.T